Turning Cell Signaling against Cancer
Researchers Use Single-Molecule Assays, Splice-Switching Oligonucleotides, and Fusion Constructs
Improvements to Gene Therapy Clinical Trial Design Benefit Hemophilia Patients
Gene Therapy Allows Hemophilia Patients to Give Up Medication, Avoid Bleeds; but More Improvements Are Needed
Genome-Wide Analysis of the Transcription Start Sites and Promoter Motifs of Phytoplasmas
RNA-Seq of Phytoplasmas Reveals Clues about Transcription Start Sites and Consensus Promoter Sequences
Virus Supply Vexes Gene Therapy Developers, CMOs
Some Contract Manufacturing Organizations Are Ramping Up Capacity in Preparation for a Boom in Viral Vector Demand
For full access to this article login to GEN Select now.
SAFC Expands to Meet Customer Demands
Firm Focuses on Technology Upgrades and QA/QC for Increasingly Specialized Products
- Suppliers to the biotechnology market, like Sigma-Aldrich’s SAFC division, are kept on their toes by constantly evolving customer demands. As a result, vendors have built larger and larger catalogs of products, moving into complex and challenging areas over the years. Diversity has been a fundamental component of SAFC’s ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.